SEC Form 4 · accession 0001487371-18-000101
GenMark Diagnostics, Inc. · GNMK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Anne Williams
Officer — SVP, Human Resources
Period of report
May 18, 2018
Accepted (ET)
May 18, 2018 · 7:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001487371
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 18, 2018 | S | 23,688 | $6.90 | D | 197,856 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $6.89 to $6.94 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.